针对儿童的Helicobacter pylori根除疗法
Kairat Rysbekov1, Sagira Abrakhmanova1, Rashida Satybaeva1
1Department of Pediatric Diseases with Courses Cardio-Rheumatology and Gastroenterology, 217968 Astana Medical University , Astana, Kazakhstan.
Drug metabolism and personalized therapy
|July 12, 2024
概括
补充维生素D并没有改善Helicobacter pylori根除率,当添加到标准的三重疗法. 该研究发现,随着维生素D的加入,治疗效率没有显著增加.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
背景情况:
- * Helicobacter pylori (H. pylori) 感染是儿童胃肠道问题的常见原因.
- *标准的三重疗法是H.pylori根除的主要治疗方法.
- *维生素D在H. pylori根除中的作用尚未得到充分证实.
研究的目的:
- * 评估维生素D补充剂对H. pylori根除治疗成功率的影响.
- * 探索潜在的新药物组合,以消除H. pylori.
主要方法:
- * 一项涉及128名被诊断患有H. pylori感染的儿童的受控研究.
- *A组接受标准三重疗法加维生素D;B组仅接受标准三重疗法.
- *测量了维生素D水平,并在治疗后45天评估了根除成功.
主要成果:
- *整体H. pylori根除成功率为84.1%.
- *A组 (使用维生素D) 的成功率为93.5%,而B组 (不使用维生素D) 的成功率为75%.
- *A组和B组之间根除率的差异没有统计学意义 (p=0.082).
结论:
- *将维生素D添加到标准的三重治疗中,以消除H. pylori在儿童中,并没有显著提高治疗疗效.
- *维生素D补充似乎不是当前的H. pylori根除方案的有益补充.
更多相关视频
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
348
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
348
01:26Peptic Ulcer Disease IV: Management
85
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
85
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
109
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
109
01:30Peptic Ulcer Disease I: Introduction
162
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
162
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
365
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
365
01:23Gastritis III: Clinical Manifestations and Management
209
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
209